Enterocolitis: Clinical Trials

2 trials for Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 2
Phase 21Active not recruiting 1

Follow Enterocolitis: new trials by email Literature Review of Enterocolitis trials Research Report on Enterocolitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 3Active not recruitingInfant Bacterial Therapeutics21582019-07-042024-04-12
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23

Narrower conditions

Enterocolitis, Necrotizing (2)  ·  Sepsis (1)

Broader conditions

Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)

Sponsors

Infant Bacterial Therapeutics (1)  ·  Thomas Abrahamsson, MD, PhD (1)

Countries

Bulgaria (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Poland (1)  ·  Romania (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Josef Neu, MD (1)  ·  Thomas R Abrahamsson, MD, PhD (1)

Results publications

PMID 34815288, PMID 38545091, PMID 38556499, PMID 40348496